MMMariana Mendes-Braz

Mariana Mendes-Braz

*This is an algorithmically generated author record based on publicly available information.

Mariana Mendes-Braz has a total of 234 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    New Perspectives on the Use of Sub-Optimal Donor Livers

    by Maria Eugenia Cornide-Petronio, Mariana Mendes-Braz, Mónica B. Jiménez-Castro, Jordi Gracia-Sancho, Carmen Peralta

    Liver transplantation is the therapy of choice for patients with end-stage liver disease. However, a shortage of donor organs remains a major obstacle to the widespread application of liver transplantation. To overcome this problem, transplant centers have developed strategies to expand the organ donor pool, including the routine use of sub-optimal donor livers. However, these have an increased risk of initial poor function or primary non-function that may cause greater risk of morbidity in the recipient. This chapter aims to describe the pathophysiological changes that may occur in sub-optimal donor livers, focusing on viral infections, since, after transplantation, infection of the graft is almost universal and can lead to chronic hepatitis, cirrhosis, and graft failure. The different experimental models as well as the clinical outcomes of the transplantation of sub-optimal donor livers with viral infections will be discussed. Such information may be useful to guide the design of better experimental models than those described to date as well as the effective use of sub-optimal livers with successful clinical application.

  • Open Access

    Diabetes Mellitus and Liver Surgery: The Effect of Diabetes on Oxidative Stress and Inflammation

    by Mariana Mendes-Braz, Joilson O. Martins

    Diabetes mellitus(DM) is a metabolic disorder characterized by hyperglycaemia and high morbidity worldwide. The detrimental effects of hyperglycaemia include an increase in the oxidative stress (OS) response and an enhanced inflammatory response. DM compromises the ability of the liver to regenerate and is particularly associated with poor prognosis after ischaemia-reperfusion (I/R) injury. Considering the growing need for knowledge of the impact of DM on the liver following a surgical procedure, this review aims to present recent publications addressing the effects of DM (hyperglycaemia) on OS and the inflammatory process, which play an essential role in I/R injury and impaired hepatic regeneration after liver surgery.


  • Open Access

    The impact of cortisol in steatotic and non‐steatotic liver surgery

    by María Eugenia Cornide‐Petronio, Esther Bujaldon, Mariana Mendes‐Braz, Cindy G. Avalos de León, Mónica B. Jiménez‐Castro, Ana I. Álvarez‐Mercado, Jordi Gracia‐Sancho, Juan Rodés, Carmen Peralta

    The intent of this study was to examine the effects of regulating cortisol levels on damage and regeneration in livers with and without steatosis subjected to partial hepatectomy under ischaemia–reperfusion. Ultimately, we found that lean animals undergoing liver resection displayed no changes in cortisol, whereas cortisol levels in plasma, liver and adipose tissue were elevated in obese animals undergoing such surgery. Such elevations were attributed to enzymatic upregulation, ensuring cortisol production, and downregulation of enzymes controlling cortisol clearance. In the absence of steatosis, exogenous cortisol administration boosted circulating cortisol, while inducing clearance of hepatic cortisol, thus maintaining low cortisol levels and preventing related hepatocellular harm. In the presence of steatosis, cortisol administration was marked by a substantial rise in intrahepatic availability, thereby exacerbating tissue damage and regenerative failure. The injurious effects of cortisol were linked to high hepatic acethylcholine levels. Upon administering an α7 nicotinic acethylcholine receptor antagonist, no changes in terms of tissue damage or regenerative lapse were apparent in steatotic livers. However, exposure to an M3 muscarinic acetylcholine receptor antagonist protected livers against damage, enhancing parenchymal regeneration and survival rate. These outcomes for the first time provide new mechanistic insight into surgically altered steatotic livers, underscoring the compelling therapeutic potential of cortisol–acetylcholine–M3 muscarinic receptors.


  • Open Access

    The Effect of High-Mobility Group Box 1 in Rat Steatotic and Nonsteatotic Liver Transplantation From Donors After Brain Death

    by M. E. Cornide‐Petronio, E. Negrete-Sánchez, M. Mendes-Braz, A. Casillas-Ramírez, E. Bujaldon, N. Meroño, L. Martínez-Carreres, J. Gracia-Sancho, J. Rodés, M. B. Jiménez‐Castro, et al.


  • Open Access

    Contents

    by Scott L. Friedman, Didier Samuel, Markus Peck‐Radosavljevic, Mary E. Charlton, Thomas Dick, Claudia Wegscheid, Kamran Karimi, Gisa Tiegs, Peter Fickert, Angelo Andriulli, et al.

  • 564 TLR4 INDUCTION BY TUDCA IN EXPERIMENTAL MODELS OF SYNGENEIC AND ALLOGENEIC STEATOTIC LIVER TRANSPLANTATION

    by M.B. Jiménez-Castro, M. Elias-Miró, M. Mendes-Braz, M. Massip-Salcedo, A. Rimola, J. Rodés, A. Casillas-Ramírez, C. Peralta